Neuromuscular Disorders
description
Transcript of Neuromuscular Disorders
![Page 1: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/1.jpg)
Neuromuscular Disorders
Rebecca Burton-MacLeodR4, Emergency Med
April 26th, 2007
![Page 2: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/2.jpg)
Objectives • Discuss pathophys• Classification schemes• Specific disorders• Cases • A few fun pics…
![Page 3: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/3.jpg)
Main concerns
• Respiratory compromise!!!!• Altered vision• Difficulty swallowing• Difficulty speaking• Motor failure
Bulbar symptoms
![Page 4: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/4.jpg)
Determining level
• Brainstem and above:– Unilateral weakness
usually– If bilateral weakness
then associated CN involvement or altered mental status
• CNS o/e: – Spasticity– Hyperreflexia– Positive Babinski– No fasciculations
• PNS:– Dec muscle tone– Hyporreflexia– Atrophy– Fasciculations– Negative Babinski
![Page 5: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/5.jpg)
Definitions
• Myelopathies—involve spinal cord• Radiculopathies—involve nerve roots as
they leave spinal cord• Neuropathies—involve peripheral nerves• Myopathies—involve muscles
![Page 6: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/6.jpg)
Neuromuscular junction
• Link between CNS and MSK• Depolarization of neuron causes release of
neurotransmitters at nerve terminal (Ach), which binds to muscle fiber receptor and initiates another wave of depolarization causing muscle contraction
• Must have: sufficient quantity of neurotransmitters AND adequate number of receptors on postsynaptic membrane
![Page 7: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/7.jpg)
NMJ
• Nicotinic synapse:– Muscle weakness– Disorders of
postsynaptic membrane
• Muscarinic synapse:– Anticholinergic
symptoms– Presynaptic and
synaptic disorders
![Page 8: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/8.jpg)
Etiologies
• Congenital—congenital MG, Achesterase deficiency
• Infectious—botulinum • Autoimmune—MG, Lambert-Eaton s/o• Toxins—snake/scorpions,
organophosphates• Drugs—Mg, aminoglycosides,
fluoroquinolones
![Page 9: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/9.jpg)
NMJ disorders
Presynaptic Synaptic Postsynaptic
Lambert-Eaton s/o
Organophosphate poisoning
Myasthenia gravis
Botulism Ach-esterase deficiency
Congenital MG
HyperMg Snake venom
Scorpion/spider toxin
![Page 10: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/10.jpg)
History—specific features
• General:– Cranial muscle
weakness– Proximity muscle
weakness– Resp muscle
involvement
• Presynaptic:– Improvement after
initiation of activity– Autonomic
involvement• Postsynaptic:
– Improvement in strength after rest
![Page 11: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/11.jpg)
Clinical characteristics Hx Strength DTR Sensation Wasting
Myelopathy
Motor neuron disNeuropathy
NMJ dis
Myopathy
![Page 12: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/12.jpg)
Clinical characteristics cont’d Hx Strength DTR Sensation Wasting
Myelopathy Trauma, infx, ca
N to dec Inc N to dec No
Motor neuron dis
Neuropathy
NMJ dis
Myopathy
![Page 13: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/13.jpg)
Clinical characteristics cont’dHx Strength DTR Sensation Wasting
Myelopathy Trauma, infx, ca
N to dec Inc N to dec No
Motor neuron dis
Progressive prob swallow, speak, walk
Dec Inc N Yes
Neuropathy
NMJ dis
Myopathy
![Page 14: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/14.jpg)
Clinical characteristics cont’d Hx Strength DTR Sensation Wasting
Myelopathy Trauma, infx, ca
N to dec Inc N to dec No
Motor neuron dis
Progressive prob swallow, speak, walk
Dec Inc N Yes
Neuropathy Recent infxn N to decDist>prox
Dec Dec Yes
NMJ dis
Myopathy
![Page 15: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/15.jpg)
Clinical characteristics cont’d Hx Strength DTR Sensation Wasting
Myelopathy Trauma, infx, ca
N to dec Inc N to dec No
Motor neuron dis
Progressive prob swallow, speak, walk
Dec Inc N Yes
Neuropathy Recent infxn N to decDist>prox
Dec Dec Yes
NMJ dis Food, ticks, easy fatigue
N to fatigue
N N No
Myopathy
![Page 16: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/16.jpg)
Clinical characteristics cont’d Hx Strength DTR Sensation Wasting
Myelopathy Trauma, infx, ca
N to dec Inc N to dec No
Motor neuron dis
Progressive prob swallow, speak, walk
Dec Inc N Yes
Neuropathy Recent infxn N to decDist>prox
Dec Dec Yes
NMJ dis Food, ticks, easy fatigue
N to fatigue
N N No
Myopathy Thyroid dis, prev similar
Dec prox>dist
N N yes
![Page 17: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/17.jpg)
Case
• 65M who has been noticing difficulty swallowing. 2x visits to ED in last 3months for esophageal obstructions due to food boluses. Also notices double vision after reading for a while, generalized fatigue.
• O/e: ptosis of L eye. Normal PERL. Rapid neuro screen otherwise normal.
• Any thoughts?
![Page 18: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/18.jpg)
Myasthenia gravis
• Causes fluctuating, fatigable weakness of voluntary muscles
• Incidence 14/100,000• Bimodal distribution—2nd/3rd decades (F),
and then 6th/7th decades (M)• Association with thymic hyperplasia (70%
pts), thymoma (15% pts)
![Page 19: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/19.jpg)
MG pathophys
• Ach-R loss due to:– Accelerated endocytosis and degradation of
receptors– Complement-mediated damage– Functional blockade of Ach-R (minor
contributor)
![Page 20: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/20.jpg)
Clinical course
• 85% pts generalized weakness within 1yr• 85% pts have max severity of illness within
5yrs of onset of symptoms• <50% pts have remissions• Extremely variable course of illness
![Page 21: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/21.jpg)
Severity classification
• Bella and Chad’s classification:– Class 1—any ocular muscle weakness, but
other strength is normal– Class 2—mild weakness other than ocular
muscles– Class 3—moderate weakness other than ocular– Class 4—severe weakness other than ocular– Class 5—intubation
![Page 22: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/22.jpg)
S/S MG
Ptosis, diplopia, blurred vision 53%
Limb weakness (arms>legs; symmetrical; proximal)
10%
Generalized fatigue 10%
Dysphagia 5%
Slurred/nasal speech 5%
Difficulty chewing 5%
![Page 23: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/23.jpg)
Diagnosis • Physical exam:
– Normal reflexes, sensation, coordination– Asymmetrical ptosis– Symmetrical, fluctuating EOM weakness– Normal PERL– Fatigability
• Tests:– Tensilon test– Ice test – Immune testing – EP studies
![Page 24: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/24.jpg)
Tensilon test
• IV edrophonium 1-5mg IV (tensilon) provides rapid (within 30sec) and short acting (~5min) improvement of ocular symptoms in pts with MG
• Edrophonium is Ach-esterase inhibitor• **always have atropine at bedside as may
cause bradycardia!!
![Page 25: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/25.jpg)
Ice test
• Cooling improves MG symptoms, heat exacerbates
• Measure distance b/w upper and lower eyelids
• Apply icepack x2min then measure again (should improve >2mm for positive MG)
• Positive in 80% of pts with MG
![Page 26: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/26.jpg)
Other tests
• Ach-R Ab levels (present in 90-95% pts)• EP studies—repetitive nerve stimulation
shows decremental response in MG
![Page 27: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/27.jpg)
Mgmt
• Anticholinesterase agents (pyridostigmine first-line; lose efficacy over time)
• Immunosuppression (steroids reduce levels of Ach-R Ab; transient exacerbation after initiation so should be hospitalized)
• Thymectomy (59% pts show sustained improvement post-op)
• Plasmapheresis• IVIG
![Page 28: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/28.jpg)
Disposition
• Any suspected MG case requires neuro consult / close f/u
![Page 29: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/29.jpg)
Case
• 43F brought in by EMS after sudden resp failure at work. Hx from colleagues of “muscle disorder” and taking steroids, which were recently d/c. Also doubled the dose of her other med “?” 1wk ago.
• Pt unable to speak, only nods head slightly. Obviously shallow resps. ++salivation, incontinent, bradycardic.
• Any thoughts?
![Page 30: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/30.jpg)
Myasthenic crisis • True emergency!• Often underlying precipitating event (infection,
changes in meds)• Weakness due to MG progression or else complication
of anticholinesterase therapy (cholinergic crisis)• Thus d/c all anticholinesterase meds if suspect
myasthenic crisis• Support ventilation, ICU admission,
plasmapheresis/IVIG, high-dose steroids (only if airway secured)
![Page 31: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/31.jpg)
Case
• 62M with known SCC lung Ca. c/o generalized leg weakness. Difficulty climbing stairs. Also c/o dry mouth and erectile dysfxn.
• O/e: testing grip strength—initially weak, then strengthens, then weakens again; hyporeflexia in LE
• Any thoughts?
![Page 32: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/32.jpg)
Lambert-Eaton s/o
• Rare autoimmune condition• Primary cause, also paraneoplastic d/o (3%
of pts with SCC of lung…may precede diagnosis)
![Page 33: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/33.jpg)
LES pathophys
• Insufficient release of neurotransmitter at presynaptic terminal
• Ab-blockade of voltage-gated Ca channels results in dec Ca influx and deficient neurotransmitter release
![Page 34: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/34.jpg)
LES diagnosis
• Classic triad—muscle weakness (legs, prox), hyporeflexia, autonomic symptoms
• EP studies—resting action potential is low, decrement with slow repetitive stimulation; with rapid stimulation causes doubling from baseline amplitude
![Page 35: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/35.jpg)
Mgmt
• R/o underlying Ca• Anticholinesterase agents (pyridostigmine)• Neurotransmitter enhancers
(aminopyridines):– K-channel blockers prolongs AP and keeps Ca
channels open longer resulting in inc Ca influx and neurotransmitter release
• Immunosuppression
![Page 36: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/36.jpg)
Case
• 6mo M presented to ED with parents• 3day hx of URTI symptoms
– Small cough, Congestion,Tactile fever, Symptoms worsening today, Friend with similar URTI symptoms week prior
• Normally BF, pt has been refusing any fluids for 2days
• No BM x 2days• PMHx: healthy
![Page 37: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/37.jpg)
Case cont’d
• O/E:– 37.9C 142 52 87% r/a – Child appears lethargic– Lungs—wheezing L>R– Pt mildly dehydrated
• Any thoughts?
![Page 38: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/38.jpg)
Case cont’d
• During ICU stay:– Hx of poor sucking prior to admission– Pt being given “bactrex”—homeopathic supplement
containing a wealth of ingredients to ‘boost the immune system’
– Noted to have profound generalized muscle weakness on exam
– No BM x2weeks despite aggressive bowel routine– Pulmonary, ID, Neurology involved in care
![Page 39: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/39.jpg)
Botulism
• 5 types of botulism:– Food-bourne (ingestion of pre-formed heat
labile toxin)– Infant (ingestion of spores with in vivo toxin
produced)– Wound (IVDU)– Unclassified– Inadvertent (botox injections)
![Page 40: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/40.jpg)
Pathophys
• Most cases caused by strains A, B, E (7 strains exist) of clostridium botulinum
• Most potent biologic toxins known– Doses of 0.05-0.1mcg can cause death in adults
• Toxin transported from GI tract/wound to neuron, toxin irreversibly binds to presynaptic nerve membrane and internalized, blocks release of Ach resulting in neuromuscular blockade
• Primarily occurs at cholinergic synapses of CN, autonomic nerves, NMJ
![Page 41: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/41.jpg)
MoA
Horowitz BZ. Botulinum toxin. Crit Care Clinic. 2005.
![Page 42: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/42.jpg)
Diagnosis
• CN findings in presence of GI symptoms and associated anticholinergic symptoms
• Onset usually within 12-36hrs after ingestion• Symmetrical, descending, rapidly progressive
weakness (may occur within 24hrs)• Suspect wound botulism in IVDU with bulbar
findings
![Page 43: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/43.jpg)
Diagnosis • C. botulinum toxin
positive in stool (60% of pts)
• Normal nerve conduction studies
• EMG may show findings consistent with acute denervation; rapid repetitive nerve stimulation shows incremental response
Fox CK et al. Recent advances in infant botulism. Pediatr Neurol. 2005.
![Page 44: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/44.jpg)
Mgmt
• Supportive measures• Although sepsis on differential, avoid use of
aminoglycosides– Have neuromuscular blocking activity which may
exacerbate botulinum blockade– Study of 99 infantile botulism pts, 61% required
mechanical ventilation if received aminoglycoside vs. 26% if no aminoglycoside given
Wilson R et al. Clinical characteristics of infant botulism in the US. Ped Infect Dis. 1982.
![Page 45: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/45.jpg)
Antitoxin ?
• BabyBIG– Approved in 2003 by FDA for cases of proven
infantile botulism– Ig prepared from plasma of donors immunized
with botulinum toxoid– Cost is $45,000 US per infant, shipped from the
US – Significantly decreases LOS hospital/ICU,
length of mechanical ventilation
![Page 46: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/46.jpg)
Case
• 28F G1P0 develops eclampsia in Cranbrook. Call to STARS. Pt retrieved, treated en route with Mg 5gm IV. Undergoes stat C-section on arrival at FMC. Post-op, unable to extubate pt.
• Any thoughts?
![Page 47: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/47.jpg)
Medications causing NM d/o
• D-penicillamine causes iatrogenic MG• Aminoglycosides, chloroquine, and
fluoroquinolones all may have pre- and post-synaptic effects
• Mg…
![Page 48: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/48.jpg)
HyperMg
• Mg regulates Ca in presynaptic membrane thru voltage-gated Ca channels by blocking Ca influx
• Prevents exocytosis of neurotransmitter• Also causes anticholinergic symptoms• Also potentiates action of NMB agents to
produce prolonged respiratory weakness
![Page 49: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/49.jpg)
Case
• 22F comes to ED with difficulty raising arms—noticed while fixing hair over last couple of weeks. Also c/o pain in shoulders bilaterally.
• O/e: periorbital heliotrope rash!!• Any thoughts?
![Page 50: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/50.jpg)
Dermatomyositis
• Weakness, pain, tenderness of involved muscles
• Inflammatory myopathy (also polymyositis)– PM does not have classic skin findings
• Associated inc risk of ca—breast, ovary, lung, GI, lymphoproliferative
![Page 51: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/51.jpg)
Diagnosis
• R/o metabolic cause with lytes (inc/dec K, Ca, dec Ph, Mg)
• Check CK– Interpret with clinical picture!– Should not be sufficient rhabdo to cause renal
failure• EMG, muscle biopsies
![Page 52: Neuromuscular Disorders](https://reader034.fdocuments.in/reader034/viewer/2022051218/56815e0c550346895dcc66f4/html5/thumbnails/52.jpg)
Mgmt
• Prednisone 1-2mg/kg/d• Cytotoxic drugs for acute exacerbations:
– Azathioprine– Methotrexate